InvestorsHub Logo

biosectinvestor

08/23/21 2:45 PM

#397510 RE: GermanCol #397509

Really well said and interesting points GermanCol. Thanks for that enlightening perspective.

Flexroy

08/23/21 2:48 PM

#397513 RE: GermanCol #397509

Thx for your post. cheers

trocprofit

08/23/21 3:01 PM

#397519 RE: GermanCol #397509

To me it reads that the Company hold both those cards. "Contingent on releasing clinical trial data" and contingent on there being "A next private placement after this release"

Lienholders get nothing extra if company never releases trial data or has another private placement.

exwannabe

08/23/21 3:27 PM

#397528 RE: GermanCol #397509

Or, the lenders see little value in an option that expires before the potential binary event, so structured the deal to have the option after TLD.

All the talk of this loan indicating result timeframes is a total joke.

JerryCampbell

08/23/21 3:34 PM

#397529 RE: GermanCol #397509

I see one major problem with your scenario.

Disclosing anything about the trial to such investors would constitute "selective disclosure" of material non-public information. That's illegal under US securities law, and not a mistake likely to be made by the 2 lawyers running nwbo.

Horseb4CarT

08/23/21 4:17 PM

#397552 RE: GermanCol #397509

Great job of connecting the dots and seeing the dots in the first place!

Agree that this is a positive indicator!

Poor Man -

08/23/21 4:24 PM

#397558 RE: GermanCol #397509

I think we so assume the release of positive TLD that we just take that kind of structure for granted. But really we shouldn’t.

Good to have it highlighted,

Bright Boy

08/23/21 4:29 PM

#397562 RE: GermanCol #397509

You're 100% !!!!! And that's why its hard to believe we're at $1.20. We should be at least North of $4 or $5:):):):)

Pharmboy46

08/24/21 1:38 PM

#397704 RE: GermanCol #397509

I like you reasoning. Thank you for your contribution!